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Isoflurane produces antidepressant 
effects and induces TrkB signaling 
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A brief burst-suppressing isoflurane anesthesia has been shown to rapidly alleviate symptoms of 
depression in a subset of patients, but the neurobiological basis of these observations remains 
obscure. We show that a single isoflurane anesthesia produces antidepressant-like behavioural effects 
in the learned helplessness paradigm and regulates molecular events implicated in the mechanism 
of action of rapid-acting antidepressant ketamine: activation of brain-derived neurotrophic factor 
(BDNF) receptor TrkB, facilitation of mammalian target of rapamycin (mTOR) signaling pathway and 
inhibition of glycogen synthase kinase 3β (GSK3β). Moreover, isoflurane affected neuronal plasticity by 
facilitating long-term potentiation in the hippocampus. We also found that isoflurane increased activity 
of the parvalbumin interneurons, and facilitated GABAergic transmission in wild type mice but not in 
transgenic mice with reduced TrkB expression in parvalbumin interneurons. Our findings strengthen the 
role of TrkB signaling in the antidepressant responses and encourage further evaluation of isoflurane as 
a rapid-acting antidepressant devoid of the psychotomimetic effects and abuse potential of ketamine.
Major depression is a highly disabling psychiatric disorder, the most significant risk factor for suicide and one of 
the biggest contributors to the disease burden worldwide1, 2. Clinical effects of the classical antidepressants appear 
slowly and many patients respond to them poorly if at all3. Electroconvulsive therapy (ECT) remains the treat-
ment of choice for treatment-resistant depression but repeated ECT produces cognitive side effects. Thus, there is 
a huge unmet medical need for more efficacious and rapid-acting treatments for major depression.
Discovery of the remarkable rapid antidepressant effect of the N-methyl-D-aspartate receptor (NMDA) 
blocker ketamine in treatment-resistant patients has inspired renewed enthusiasm towards antidepressant drug 
development4. However, the psychotomimetic properties and abuse potential limit the clinical use of ketamine5. 
Emerging evidence suggests that the rapid antidepressant effects of ketamine are mediated by α-amino-3-hydroxy- 
5-methyl-4-isoxazolepropionic acid (AMPA) receptor dependent fast synaptic transmission and the release of 
brain-derived neurotrophic factor (BDNF) that further leads to increased signaling of the TrkB-mTOR (mam-
malian target of rapamycin) pathway, alterations in dendritic spine dynamics, synaptic plasticity and animal 
behaviour6–8. Inhibition of glycogen synthase kinase 3β (GSK3β) is another molecular signaling event recently 
implicated in the antidepressant mechanisms of ketamine9. These effects set forth by ketamine co-associate with 
altered GABAergic interneuron function10.
Brief deep isoflurane anesthesia has been shown to produce rapid antidepressant effects in both double-blind and 
open-label clinical studies11–14. The clinical observations have been, however, partially inconsistent (see refs 15, 16), 
which has reduced the interest to thoroughly evaluate isoflurane as an alternative for ECT and ketamine. To this 
end, we have translated the treatment concept into preclinical settings and evaluated its antidepressant-like and 
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neurobiological effects in rodents. We show that a single isoflurane anesthesia rapidly transactivates TrkB, regu-
lates the mTOR and GSK3β signaling pathways as well as activity and function of GABAergic interneurons, facil-
itates hippocampal long-term potentiation and produces antidepressant-like behavioural responses in rodents. 
These findings shed light on the neurobiological basis of clinically observed rapid-acting antidepressant effects 
of isoflurane and may become instrumental in dissecting shared mechanisms underlying rapid antidepressant 
responses.
Results
Antidepressant-like behavioural effects of isoflurane in rodents. The rat learned helplessness 
model (LH) has good face, construct and predictive validity regarding depression17, 18. Whereas long-term treat-
ment with classical antidepressants is required to ameliorate the learned helplessness phenotype18, ketamine pro-
duces essentially similar antidepressant-like behavioural effect in the model already after a single treatment19. 
Consequently, we employed this model to investigate the potential antidepressant-like effects of isoflurane. 
Indeed, as shown in Fig. 1A, already a single exposure to isoflurane anesthesia produced an antidepressant-like 
effect (reduced failure to escape from the compartment where the animal receives footshocks) in the LH when the 
phenotype was assessed at 6 days post-treatment.
Chronic pain is strongly associated with depression20, 21 and previous studies show that persistent neuro-
pathic pain induces behavioural abnormalities typical for depression and anxiety in mice22. Thus, we evaluated 
the antidepressant-like effects of a single isoflurane anesthesia treatment also in this model. As expected, mice 
subjected to the sciatic nerve cuffing showed depression-like phenotype (delayed latency to eat food pellet) in the 
novelty-suppressed feeding (NSF) test at 8-weeks post-surgery (Fig. 1B). Importantly, the phenotype was reversed 
in the nerve-cuffed animals exposed to isoflurane at 12 hours before the testing (Fig. 1B). The antidepressant-like 
effects of isoflurane appeared very rapidly in this test compared to classical antidepressants, which require weeks 
of repeated administration to show similar actions23. Of note, isoflurane did not have antinociceptive effects 
against the mechanical allodynia produced by the model (Fig. 1C).
Isoflurane anesthesia rapidly activates TrkB receptors. Essentially all antidepressants, including ket-
amine, have been shown to rapidly, within an hour, activate BDNF receptor TrkB and this effect is proposed to 
be critically involved in the mechanism of action of antidepressants7, 24–26. To test the intriguing possibility that 
isoflurane might bring about similar responses on TrkB, we subjected adult mice to a brief isoflurane treatment 
and collected brain samples and assayed the TrkB phosphorylation status. Deep burst-suppressing isoflurane 
anesthesia (induction 4%, maintenance ~2% ad 30 min; see ref. 27), which is shown to elicit rapid antidepressant 
effects in patients11, 13, robustly increased the phosphorylation of TrkB (pTrkB) in the medial prefrontal cortex 
(mPFC) (Fig. 2A), hippocampus (HC) (Fig. 2B) and the somatosensory cortex (Supplementary Figure 1) of adult 
naïve mice while subanesthetic isoflurane (0.3%) produced no such effects (Fig. 2C). The ability of isoflurane 
anesthesia to induce pTrkB is extremely fast and transient; a significant increase in pTrkB levels was observed 
within two minutes from the treatment onset and the TrkB phosphorylation returned close to baseline already at 
15 min after the termination of anesthesia (Fig. 2D).
When transgenic mice over-expressing flag-tagged TrkB in neurons28 were treated with isoflurane, an increase 
in pTrkB was seen in the flag-antibody precipitated samples (Fig. 2E), demonstrating the specificity of the effect 
on TrkB. Since the transgene expression in this mouse line is directed to postnatal neurons28, this result also 
Figure 1. A single brief isoflurane anesthesia produces antidepressant-like behavioural effects in rodents (A) 
A single isoflurane anesthesia (30 min) decreases the escape failures in the learned helplessness test when tested 
6 days after the anesthesia (p = 0.0296; n = 7). (B) Mice subjected to right common sciatic nerve cuffing show 
anxiodepressive behaviour (increased latency to feed) in the novelty suppressed feeding test. Such phenotype 
is not seen in mice exposed to a single isoflurane anesthesia (30 min) at 12 hours before testing (two-way 
ANOVA: cuffing*treatment interaction F3,27 = 6,398, p = 0.018; nsham ctrl = 8, nsham iso = 8, ncuff ctrl = 8, ncuff iso = 7). 
(C) Control and isoflurane-treated mice subjected to the right sciatic nerve cuffing show essentially similar 
mechanical allodynia in the von Frey test 8-weeks post-surgery (Two-way ANOVA: surgery F1,24 = 123.19, 
p < 0.001, treatment F1,24 = 0.52, p = 0.47, surgery x treatment interaction F1,24 = 0.006, p = 0.93). The experiment 
was performed 3 days before and 2 days after control or isoflurane treatment. *p < 0.05, **p < 0.01; Statistical 
analysis was done using Student’s t test (A) or two-way ANOVA (B, C). Abbreviations: CTRL, control treatment; 
ISO, isoflurane treatment; Sham, sham surgery; Cuff, cuff surgery; NSF, novelty suppressed feeding test.
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confirms that the pTrkB response takes place in neurons. Isoflurane treatment increased tyrosine phosphoryl-
ation of TrkB at the autocatalytic domain (Y706/7) and at the phospholipase-Cγ1 (PLCγ1) binding site (Y816) 
but not at the Shc binding site (Y515) (Fig. 2E), which is consistent with our previous findings with the classical 
monoamine-based antidepressants24, 26. Notably, similar changes in pTrkB were also observed after anesthesia 
with halothane or sevoflurane (Supplementary Figure 2).
TrkB activation is necessary for the antidepressant-like responses to isoflurane in the forced 
swim test. The forced swim test (FST) is an acute behavioural test used for screening of compounds with 
antidepressant potential in naïve animals29. Indeed, mice tested 15 minutes after the termination of isoflurane 
anesthesia showed significantly reduced immobility in the FST compared to sham-treated animals (Fig. 2F). 
The acute behavioural change produced by isoflurane anesthesia was likely not due to an overall increase in 
locomotor activity, since isoflurane-treated mice showed reduced rather than enhanced activity in the open 
field test (Supplementary Figure 3). Importantly, the effects of isoflurane in the FST were absent in mice 
over-expressing the dominant-negative truncated TrkB.T1 isoform (Fig. 2F). This finding is consistent with the 
loss of behavioural effects of classical antidepressants in these mice24 and suggests that TrkB is required also for 
the antidepressant-like effects of isoflurane in the FST.
Isoflurane regulates intracellular signaling implicated in antidepressant responses. Classical 
antidepressant drugs have been shown to activate the transcription factor cAMP response element binding 
protein (CREB) downstream of TrkB24, 26. Along with this change, ketamine has been shown to activate pro-
tein kinase B (Akt) and mTOR signaling pathways and phosphorylate GSK3β to the inhibitory Ser9 residue6, 7, 9. 
Ketamine-induced activation of mTOR further leads to phosphorylation and activation of p70S6k and eukary-
otic initiation factor 4E binding protein 1 (4E-BP1). Isoflurane anesthesia produced remarkably similar phos-
phorylation changes on all these intracellular signaling molecules: the phosphorylation levels of CREBSer133, 
AktT308, mTORS2481, p70S6KT421/S424, 4EBP1T37/46 and GSK3βS9 were significantly increased at 30 minutes after 
the onset of isoflurane anesthesia in the mouse mPFC (Fig. 3A). Significant phosphorylations of CREBSer133, 
p70S6KT421/S424, 4EBP1T37/46 and GSK3βS9 were also observed in the HC after 30 min isoflurane treatment, whereas 
Figure 2. Isoflurane anesthesia induces TrkB autophosphorylation in the brain and produces antidepressant-
like effects in the forced swim test. (A,B) Isoflurane anesthesia (30 min) increase phosphorylation of TrkBY816 
in the adult mouse medial prefrontal cortex (p = 0.0022) and hippocampus (p < 0.0001). (C) Effect of 
subanesthetic isoflurane (0.3%, 15 min) on phosphorylation of TrkBY816 in the medial prefrontal cortex. (D) 
Time-dependent effect of isoflurane anesthesia on TrkB phosphorylation in the medial prefrontal cortex. (E) 
Significantly increased phosphorylation of the phospholipase-Cγ1 (PLCγ1) binding site (Y816) (p = 0.0182) 
and the catalytic domain (Y706/7) of TrkB (p = 0.0426) is detected after flag-immunoprecipitation from 
hippocampus of mice overexpressing flag-tagged full-length TrkB receptors in postnatal neurons. No change is 
detected in phosphorylation of Shc binding site (Y515) of TrkB (p = 0.8623). (F) Wild-type mice treated with 
isoflurane for 30 min show reduce immobility in the forced swim test when tested 15 minutes after the end of the 
treatment, whereas in the mice over-expressing the dominant-negative TrkB.T1 isoform the effect was absent 
(two-way ANOVA genotype*treatment interaction F3,24 = 4,301, p = 0.049, n = 7). pTrkB levels normalized 
to total TrkB (A–D). Representative western blots (A,B,C,E) have been cropped from complete immunoblots 
shown in Supplementary Information file. *p < 0.05, **p < 0.01, ***p < 0.001; Mann Whitney U test, Student’s 
t test, one-way ANOVA followed by Dunnett’s post hoc test (C, all groups compared to the Ctrl) or two-way 
ANOVA followed by Tukey HSD post hoc test (E). Abbreviations: CTRL, control treatment; ISO, isoflurane 
treatment; FST, forced swim test; WT, wild-type; T1, mice overexpressing TrkB.T1; PFC, prefrontal cortex; HC, 
hippocampus.
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phosphorylation levels of AktT308 and mTORS2481 were not regulated (Fig. 3B). Similarly to the pTrkB response 
(Fig. 2D), these isoflurane-induced molecular changes were observed within minutes from the treatment onset 
(Fig. 3C). Collectively these data demonstrate that isoflurane anesthesia very rapidly regulates molecular events 
intimately associated with rapid antidepressant responses in brain areas implicated in the pathophysiology of 
major depression.
Isoflurane transactivates TrkB independently of BDNF and AMPA receptor signaling. 
Facilitation of AMPA receptor signaling and translation (and release) of BDNF through inhibition of eukaryotic 
elongation factor 2 (eEF2) are suggested to govern the effects of ketamine on TrkB6, 7, 19, 30, yet we found no clear 
evidence supporting these mechanisms for isoflurane. First, pretreatment with the AMPA receptor blocker NBQX 
(10 mg/kg, i.p.) for 10 minutes prior to isoflurane had no effect on the isoflurane-induced TrkB phosphorylation 
and downstream signaling (Fig. 4A). Moreover, phosphorylation of eEF2 and levels of BDNF (both mRNA and 
protein) remained unaltered by isoflurane at the time of TrkB phosphorylation (Fig. 4B–D). To investigate the 
role of BDNF more directly, we performed isoflurane-induced TrkB phosphorylation analyses in mice homozy-
gous for a conditional deletion of BDNF specifically in CaMKII-positive neurons. Importantly, isoflurane readily 
activates TrkB in the hippocampus of these mice (Fig. 4E) even though the BDNF protein levels are undetectable 
(Fig. 4D). Notably, essentially similar BDNF-independent acute TrkB (trans)activation has been observed with 
classical antidepressant imipramine31.
Figure 3. Isoflurane anesthesia regulates intracellular signaling implicated in rapid antidepressant actions. 
(A) Phosphorylation of AktT308 (p = 0.0084), CREBS133 (p = 0.0087), mTORS2481 (p = 0.0292), p70S6KT421/S424 
(p = 0.0022), 4-EBP1T37/46 (p = 0.0012) and GSK3βS9 (p = 0.0001) in the adult mouse prefrontal cortex after 
isoflurane anesthesia (30 min). (B) Phosphorylation of AktT308 (p = 0.3052), CREBS133 (p = 0.0014), mTORS2481 
(p = 0.7422), p70S6KT421/S424 (p = 0.0022) 4E-BP1T37/46 (p = 0.0022) and GSK3βS9 (p = 0.0001) in the adult 
mouse hippocampus after isoflurane anesthesia (30 min). (C) Phosphorylation of CREBS133, mTORS2481 and 
p70S6KT421/S424 are increased within 2 minutes from the onset of isoflurane (4%) administration. pAKT and 
pCREB levels normalized to corresponding total protein, other phosphoproteins normalized to GAPDH. n = 6/
group. Representative western blots have been cropped from complete immunoblots shown in Supplementary 
Information file. *p < 0.05, **p < 0.01, ***p < 0.001; Student’s t test. Abbreviations: CTRL, control treatment; 
ISO, isoflurane treatment; CREB, cAMP response element binding protein; Akt, protein kinase B; mTOR, 
mammalian target of rapamycin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase, GSK3β, glycogen 
synthase kinase 3β.
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Isoflurane does not regulate dendritic spine formation and turnover in the adult mouse cor-
tex. Ketamine has been shown to rapidly – within 24-hours – promote spine recovery in the PFC of stressed 
rats by enhancing the mTOR-p70S6K signaling pathway6. The ability of isoflurane to readily activate this very 
same molecular pathway prompted us investigating its effects on dendritic spines 24 hours post-anesthesia. 
However, the spine densities were not significantly different from that found in the control mice in fixed sections 
of the PFC, HC or the somatosensory cortex (Fig. 5). Since fixed tissue preparation could undermine changes 
in spine dynamics, we used in vivo 2-photon time-lapse microscopy to image individual dendritic spines in the 
same (head-fixed but otherwise freely moving in the Mobile HomeCage32) mouse at 24 hours before (control 
condition), immediately before and at 24 hours after a brief isoflurane anesthesia. Because the PFC is not easily 
accessible to in vivo 2-photon imaging, we focused on the somatosensory cortex, where isoflurane also activates 
the TrkB-p70S6k signaling pathway (Supplementary Figure 1). Spine formation and elimination rates remained 
unchanged within 24 hours before and 24 hours after isoflurane, indicating that neither spine density nor spine 
dynamics were significantly affected by isoflurane anesthesia in this region (Fig. 6).
A brief isoflurane treatment leads to the facilitation of hippocampal synaptic strength. TrkB 
signaling importantly regulates neuronal plasticity such as long-term potentiation (LTP)33. Notably, facilitation 
of LTP has been implicated in the antidepressant response5, 34. We therefore used electrophysiology in acute 
brain slices from mice treated with isoflurane 24 hours earlier to study field excitatory postsynaptic potentials 
(fEPSP) recorded in the stratum radiatum of the CA1 region of the HC and evoked by electrical stimulation of the 
Schaffer collateral pathway. Recordings of input–output relationship showed that isoflurane exposure 24 hours 
before accentuated basal synaptic transmission in the HC (Fig. 7A). Paired pulse facilitation was not affected by 
isoflurane implying unaltered release probability and presynaptic function (Fig. 7B). In slices prepared from mice 
Figure 4. Isoflurane transactivates TrkB. (A) Pre-treatment with the AMPA receptor blocker NBQX (10 mg/kg, 
i.p.) does not prevent isoflurane (15 min) induced phosphorylations of TrkB (two-way ANOVA: F3,20 = 4.379, 
p = 0.017; Tukey HSD post hoc test: CTRL vs. NBQX p = 0.972, CTRL vs. NBQX + ISO p = 0.075, CTRL vs. ISO 
p = 0.050, NBQX + ISO vs. ISO p = 0.996), CREB (two-way ANOVA: F3,20 = 24.731, p < 0.001; Tukey HSD post 
hoc test: CTRL vs. NBQX p = 0.648, CTRL vs. NBQX + ISO p < 0.001, CTRL vs. ISO p < 0.001, NBQX + ISO 
vs. ISO p = 1.000) or p70S6K (two-way ANOVA: F3,20 = 6.228, p = 0.0037; Tukey HSD post hoc test: CTRL vs. 
NBQX p = 0.859, CTRL vs. NBQX + ISO p = 0.041, CTRL vs. ISO p = 0.143, NBQX + ISO vs. ISO p = 0.916). 
pTrkB normalized to total TrkB, other phospho-proteins to GAPDH. n = 6/group. (B) The phosphorylation 
of eEF2 was not affected by isoflurane anesthesia (30 min) in the prefrontal cortex. n = 6. Student’s t test. (C) 
Total Bdnf mRNA (normalized to Gapdh mRNA) levels remain unaltered after isoflurane anesthesia (30 min) 
(nCtrl = 6; nIso = 5). (D) Mature BDNF protein levels remain unaltered after isoflurane anesthesia (30 min). 
Analysis done using ELISA and western blot. A representative western blot on right shows the mature BDNF 
band, which is absent in a sample obtained from conditional BDNF knockout (KO) mouse. (E) Isoflurane 
anesthesia activates TrkB in the hippocampus of conditional BDNF knockout mice (Two-way ANOVA 
treatment effect F3,12 = 41,843, p < 0.001; Tukey HSD post hoc test WT CTRL vs. WT ISO p = 0.001, WT CTRL 
vs. cKO ISO p = 0.015). Representative western blots (A, B, D) have been cropped from complete immunoblots 
shown in Supplementary Information file. *p < 0.05, **p < 0.01, ***p < 0.001; Abbreviations: CTRL, control 
treatment; ISO, isoflurane; AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; NBQX, 2,3-dioxo-
6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; CREB, cAMP response element binding protein; 
eEF2, Eukaryotic elongation factor 2.
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treated with isoflurane 24 hours before, tetanic stimulation (100 Hz/1 s) produced a significantly higher long-term 
potentiation (LTP) of the fEPSPs than what was seen in the control slices (Fig. 7C) (see ref. 35). These effects of 
isoflurane on synaptic strength are reminiscent of the previously reported changes seen after a long-term treat-
ment with the classical antidepressant fluoxetine, but they appear much faster36.
Isoflurane regulates the excitability of parvalbumin-containing interneurons through TrkB. To 
investigate cellular and network level correlates underlying isoflurane-induced facilitation of synaptic plasticity 
we performed FosB immunostainings on brain sections with the aim to identify neuronal populations showing 
Figure 5. Lack of effects of isoflurane anesthesia on dendritic spines in the mouse cortex and hippocampus. 
Reconstruction of confocal images showing the medial prefrontal cortex (mPFC) (A and E), the hippocampus 
(HC) (F) and somatosensory cortex (SSCx) (G) from Thy1-eYFP mice. We analyzed dendritic spine density 
of the primary apical dendrites of pyramidal neurons in three different segments of 60 µm each up to 180 µm 
from the cell soma (B; also indicated with *). Representative images of distal dendritic segment between 120 
and 180 µm (C). We also analyzed extra-distal dendritic segments in the mPFC and the HC (D; indicated as # in 
E and F). We analyzed dendritic spine densities from mice subjected to sham or isoflurane treatment (30 min) 
24-h before. Histograms showing the densities of spine subtypes in three different segments relative to the 
distance to the soma (B) in the mPFC (H; indicated as *), HC (I; *) and the SSCx (J; *). Isoflurane treatment did 
not produce changes to the spine morphology or to the total spine amount at different distances from the soma 
(2-way ANOVA: treatment effect for distance in the mPFC (F1,36 = 0.7705, p = 0.385), the HC (F1,21 = 1.371, 
p = 0.2547) and the SSCx (F1,36 = 0.02270, p = 0.8688)). Extra distal segments were also analyzed in the mPFC 
(H; indicated as #p = 0.6756) and the HC (I; #p = 0.8203). n = 7 mice/group, 3 sections/mouse, 8 dendrites/
section. Scale bar in A and D: 4 μm. Statistical analysis was done using Student’s t test (for extra distal segments 
or # in H and I) and 2-way ANOVA (for the first 180 µm from the cell soma or * in H,I and J).
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sustained activity following isoflurane administration. Interestingly, parvalbumin interneurons within the HC 
(and cortex; Supplementary Figure 4) showed the most prominent FosB immunoreactivity 24 hours after a brief 
exposure to isoflurane (Fig. 8A,B). This observation prompted us to test the role of inhibitory interneurons fur-
ther using pharmacological and genetic tools. Indeed, bath application of picrotoxin essentially abolished the 
accentuated LTP after isoflurane anesthesia, supporting a GABAA dependent mechanism (Fig. 8C). Moreover, 
spontaneous inhibitory postsynaptic currents (IPSCs) were significantly increased in CA1 pyramidal neurons in 
slices obtained from animals treated with isoflurane 24 hours before (Fig. 8D). This effect was due to altered excit-
ability of GABAergic interneurons rather than changes in GABA release, since no difference in miniature IPSCs 
were detected between control and isoflurane treated mice (Fig. 8E,F). To investigate the potential involvement 
of TrkB in these effects produced by isoflurane we performed electrophysiological studies in mice with reduced 
TrkB expression specifically in the parvalbumin interneurons (PV-TrkB+/− heterozygous cKO mice). Importantly, 
whereas the effect of isoflurane on spontaneous IPSCs was readily recapitulated in hippocampal slices obtained 
from control animals, such effect was blunted in slices obtained from PV-TrkB+/− mice (Fig. 8G). Altogether 
Figure 6. Effects of isoflurane on dendritic spine turnover in the somatosensory cortex of awake mice. (A) 
Focal plane showing expression of YFP under the thy1 promoter and the 70 kDa dextran tracer labeled with 
Texas Red which serves as map to identify the same areas during the different time points of the experiment. (B) 
Reconstruction of confocal images showing one of the dendritic segments analyzed. (C) Selected area shows a 
high magnification image of the dendrite to illustrate the spines (C1) 24 hours before, (C2) immediately before 
and (C3) 24 hours after the isoflurane administration (30 min). White arrowheads indicate stable spines, red 
arrowhead indicates eliminated spine and blue arrowhead indicates newly formed spine. Histograms represent 
(D) spine formation (p = 0.6476) and (E) elimination rate (p = 0.7301) before (pre-treatment) and after (post-
treatment) isoflurane treatment. n = 3 mice, ~300 spines/mouse were analyzed. Scale bar size corresponds to 
60 μm in A, 11.6 μm in B and 3.7 μm in C images. Statistical analysis was done using paired Student’s t test.
Figure 7. Isoflurane accentuates glutamatergic transmission and plasticity in the hippocampus. (A) Slope of 
field excitatory postsynaptic potential (fEPSP) recorded in the area CA1 plotted as a function of presynaptic 
fiber volley (PSFV) amplitude recorded in slices from mice treated with isoflurane (30 min) at 24 hours before 
(n = 12 slices/8 mice) and in control animals (n = 10 slices/7 mice) (one-way ANOVA: F1,20 = 1.314, p = 0.0479). 
(B) Paired-pulse facilitation induced by two consecutive stimuli with interpulse interval (IPI) between 10 and 
200 msec was not different between the groups (F1,10 = 0.354, p = 0.564). n = 9 slices/8 mice for isoflurane group 
and n = 10 slices/7 mice for control group. Statistical analysis was done using one-way ANOVA. (C) Long-term 
potentiation (LTP) induced by high-frequency stimulation (HFS, 100 Hz/1 s) is significantly enhanced in slices 
from isoflurane treated animals (two-way ANOVA: F1,64 = 7.91, p = 0.000896; n = 8 slices/8 mice for isoflurane 
group and n = 8 slices/7 mice for control group). Representative fEPSPs taken before and 30 min after the HFS 
are shown in the insets (control = black, isoflurane = grey).
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these studies suggest that a brief isoflurane anesthesia brings about sustained TrkB dependent changes on the 
excitability of parvalbumin containing GABAergic interneurons.
Discussion
Our study shows that isoflurane, at dosing regimen shown to bring about antidepressant effects in clinical studies11, 13, 14, 
induces TrkB phosphorylation and downstream signaling in the brain regions implicated in antidepressant 
responses, and that this signaling is accompanied by long-lasting, TrkB dependent plasticity-related physiologi-
cal and behavioural responses. Previous observations have suggested that the activation of TrkB and subsequent 
intracellular signaling are required for the behavioural effects of clinically used antidepressants, including the 
rapid-acting antidepressant ketamine7, 24. The observation that TrkB is also activated by and required for the 
behavioural effects of isoflurane in the FST strengthens the role for TrkB signaling as the common pathway for 
antidepressant actions.
While many molecular and cellular mechanisms activated by isoflurane resemble those induced by ketamine, 
there seem to be important differences in the action of these two drugs. It has been proposed that ketamine 
facilitates AMPA receptor activation, which subsequently leads to BDNF release and TrkB activation. Our data 
suggest that isoflurane (and classical antidepressants31) induces TrkB activation without the involvement of BDNF 
and AMPA receptor activation7. Notably, several neurotransmitters and modulators have been shown to trans-
activate receptor tyrosine kinases, such as TrkB, through the regulation of Src family kinases37–39. Whether such 
Figure 8. Isoflurane treatment leads to an increase in the activity of parvalbumin positive interneurons via 
activation of TrkB. (A) The intensity of FosB staining in parvalbumin positive (PV+) cells, but not somatostatin 
positive cells (SOM+) or cells not expressing PV or SOM (PV−/SOM−), is significantly increased in the 
CA1 area of hippocampus of mice treated with isoflurane 24 hours before (p = 0.0474, Student’s t test). (B) 
Representative figures of the parvalbumin, somatostatin and FosB stainings. (C) Long-term potentiation (LTP) 
induced by high-frequency stimulation (HFS, 100 Hz) is enhanced in slices from mice treated with isoflurane 
for 30 min 24 hours before. The difference between the groups disappears in the presence of picrotoxin (PiX). 
Representative fEPSPs taken 5 min before and 30 min after the HFS are shown in the insets (control = black, 
isoflurane = dark grey; control/PiX = light gray; isoflurane/PiX = gray). (D) The average frequency of 
spontaneous IPSCs in CA1 hippocampal neurons recorded at 24 hours after isoflurane anesthesia (30 min) (6 
slices/6 animals per group, ANOVA, p < 0.01) and example traces of the recordings. (E) The average frequency 
of miniature IPSC in CA1 hippocampal neurons (6 slices/6 animals per group, one-way ANOVA) is not affected 
by isoflurane treatment. (F) Decay time distribution of mIPSC (6 slices per group, Pearson’s χ2 test). (G) The 
average frequency and example traces of spontaneous IPSC in CA1 hippocampal neurons recorded 24 h after 
isoflurane anaesthesia in wild-type (WT) and PV-TrkB+/− heterozygous (KO) mice (WT; 6 slices/6 animals 
for ISO, 5 slices/5 animals for CTRL; KO - PV-TrkB+/−; 7 slices/7 animals for ISO, 5 slices/5 animals for CTRL; 
ANOVA, p < 0.05). Abbreviations: CTRL, control treatment; ISO, isoflurane treatment. *p < 0.05, **p < 0.01.
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mechanism underlies the isoflurane-induced TrkB activation remains to be investigated. Moreover, isoflurane 
significantly potentiated glutamatergic synaptic transmission but did not seem to affect synaptic structure (i.e. the 
morphology and turnover of dendritic spines), while ketamine has been shown to affect both the structure and 
function of the excitatory synapses6, 30. The lack of effects of isoflurane on dendritic spine dynamics is consistent 
with previous observations showing that anesthetics, such as isoflurane, significantly regulate dendritic spine 
number and morphology during brain growth spurt, but not in the adult brain40, 41. Unlike ketamine, however, 
the effects of isoflurane on dendritic spines have been investigated in animals not subjected to chronic stress. 
Therefore, the effects of isoflurane and ketamine on molecular signaling events, dendritic spines and neuronal 
plasticity should be investigated and directly compared in naïve animals and in various animal models of depres-
sion (e.g. social defeat stress, chronic unpredictable mild stress). The potential differences in the mechanisms of 
action between ketamine and isoflurane may become instrumental in the attempts to focus drug discovery efforts 
towards the pathways activated by both compounds.
Reduced concentration of GABA is implicated in pathophysiology of depression and it has been proposed that 
many of the currently used antidepressants ultimately act through modulation of GABAergic transmission42, 43. 
The observation that isoflurane treatment led to changes in the activity of parvalbumin (PV) positive interneu-
rons is consistent with the idea that the primary effect of isoflurane resides in the GABAergic PV interneurons, 
which regulate the activity of glutamatergic principal neurons via perisomatic inhibition10. Importantly, tetanic 
stimulation can result in interneuron-driven GABAergic excitation, leading to synchronous spiking in hippocam-
pal pyramidal neurons and thereby promoting LTP induction44, 45.
Remarkably, clinical studies conducted decades ago have shown that isoflurane therapy that induces burst 
suppressing pattern in the EEG (electroencephalogram) produces a robust and rapid antidepressant response in 
a subset of treatment-resistant depressed patients11, 13. Although some subsequent trials were unable to replicate 
these findings15, 16, a recent positive replication by Weeks et al. has renewed the interest towards isoflurane as an 
antidepressant therapy14. The antidepressant response of isoflurane appears comparable in magnitude to that 
produced by the ECT, but faster in onset; a significant antidepressant effect was observed after a single isoflurane 
treatment13. Our current results provide plausible neurobiological basis for the rapid-acting antidepressant effi-
cacy of isoflurane and encourage its further clinical evaluation in depressed patients.
This report has significant implications also outside antidepressant field. Isoflurane is a commonly used 
anesthetic agent in experimental research. With increased use of electrophysiological, imaging and optogenetic 
methods requiring surgical operations, mice are often exposed to isoflurane anesthesia prior to behavioural test-
ing. Therefore, the long-lasting physiological and behavioural responses to isoflurane treatment uncovered here 
should be taken into account when designing and interpreting behavioural assessments in animals previously 
anesthetized with isoflurane. Given the pronounced effects of anesthetics on several molecular pathways in naïve 
animals27, the use of anesthesia should be taken into account in experimental research when interpreting the data.
Materials and Methods
Detailed description of Materials and Methods are provided in the Supplementary Information file.
Animals. Adult C57BL/6J, BDNF2L/2LCk-Cre (ref. 46), B6.Cg-Tg(Thy1- YFPH)2Jrs/J, TrkBfl°x/−:PV-Cre+/− (refs 47, 48) 
heterozygous conditional knockout mice and transgenic mice over-expressing flag-tagged TrkB or truncated TrkB.
T128, 49, 50 and their wild-type littermates were used. Adult male Wistar rats were used for learned helplessness 
test. The learned helplessness studies were conducted in conformity with the Brazilian Council for the Control 
of Animals under Experiment (CONCEA) and were approved by the local ethical committee of University of São 
Paulo at Ribeirão Preto campus. The experiments involving neuropathic pain model were performed in accord-
ance with guidelines for animal experimentation of the International Association for the Study of Pain (IASP) 
and European Communities Council Directive 86/6609/EEC and were approved by the local ethical committee 
of the University of Strasbourg (CREMEAS, n°AL-04). The experiments involving conditional BDNF mutant 
mice were performed in accordance with the National Institutes of Health Guide for Care and Use of Laboratory 
Animals guidelines and were approved by the Institutional Animal Care and Use Committee at Tufts University. 
Rest of the experiments were carried out according to the guidelines of the Society for Neuroscience and were 
approved by the County Administrative Board of Southern Finland (License numbers: ESLH-2007-09085/Ym-23, 
ESAVI/7551/04.10.07/2013).
In vivo pharmacological treatments. The following drugs were used: isoflurane (inhalation; anesthesia: 
induction ~4%, maintenance ~1–2%; see ref. 27), sevoflurane (inhalation; anesthesia: induction ~8%, mainte-
nance ~4%), halothane (as for isoflurane) and NBQX (i.p., 10 mg/kg; in saline).
Immunoprecipitation and western blot. The brain samples were homogenized in NP lysis buffer26, 
centrifuged (16000 g, 15 min, +4 °C) and the resulting supernatant used for analyses. Samples were separated 
with SDS-PAGE and blotted to PVDF membrane. Membranes were incubated with antibodies directed against 
phosphorylated or non-phosphorylated forms of Trk/TrkB, CREB, Akt, mTOR, p70S6K, 4E-BP1, GSK3β, eEF2, 
BDNF and GAPDH. Following consecutive washes and horseradish peroxidase conjugated secondary antibody 
incubations immunoreactive bands were visualized using enhanced chemiluminescence using a standard camera.
qRT-PCR and ELISA. Total Bdnf mRNA levels were measured using quantitative RT-PCR as described51. 
BDNF protein levels were analyzed using a commercial ELISA kit.
Spine analysis from fixed tissue. B6.Cg-Tg(Thy1- YFPH)2Jrs/J mice were transcardially perfused with 
4% PFA at 24 h after isoflurane/sham treatment under pentobarbital anesthesia. Floating sections (50 μm) were 
cut using a vibratome and processed for YFP immunofluorescence histochemistry using standard techniques. 
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Images were obtained using confocal microscope and pyramidal neurons from the mPFC and SSCx were selected 
with the following criteria: intense fluorescence, soma located in layer V, and primary apical dendrite >200 μm 
long. We imaged the dendrites in three ~65 μm long segments (proximal/medial/distal). We distinguished three 
types of dendritic spines: (i) stubby; (ii) mushroom and; (iii) filopodia/thin.
In vivo two-photon microscopic imaging in awake mice. B6.Cg-Tg(Thy1- YFPH)2Jrs/J mice and 
Mobile HomeCage system (Neurotar Ltd., Finland) were used for the analysis of dendritic spine turnover in SSCx 
(layer 1) in an awake in vivo imaging through cranial window implanted onto the skull above the somatosensory 
cortex. Five different dendritic segments from 4 different areas were analyzed per animal to study the time-lapse 
spine turnover52. The spine formation and elimination rates were calculated as the number of spines that have 
appeared or disappeared, respectively at a given time point compared to the previous time point relative to the 
total number of spines present at that or the previous time, respectively.
Immunohistochemistry. The tissue was processed as free-floating sections. After blocking and permeabi-
lization the sections were incubated for 48 h at 4 °C with a cocktail containing IgG mouse anti-Somatostatin, IgG 
guinea pig anti-Parvalbumin and IgG rabbit anti-FosB. After washing the sections were incubated with a cocktail 
containing the fluorescence conjugated secondary antibodies. Washed sections were mounted on slides and cov-
erslipped using fluorescence mounting medium (Dako).
Electrophysiological recordings. Hippocampal slices (400 μm) were cut with a vibratome as described53. 
Extracellular recordings from CA1 stratum radiatum were obtained with aCSF (artificial cerebrospinal fluid) 
filled glass microelectrodes (2–5 MΩ) using an Axopatch 200B amplifier. Field excitatory potentials (fEPSP) were 
evoked with a bipolar stimulating electrode placed in the Schaffer collateral pathway. LTP was induced by 100-Hz 
tetanic stimulation for 1 s. The level of LTP was measured as a percentage increase of the fEPSP slope, averaged at 
a 1-min interval 30 min after the tetanus, and compared to the averaged baseline fEPSP slope. For paired-pulse 
stimulation, interpulse intervals from 10 to 200 ms were tested. To antagonize fast GABAA synaptic transmission 
picrotoxin (PiX; 100 µM) was used. WinLTP (0.95b or 0.96, www.winltp.com) was used for data acquisition54. To 
investigate inhibitory postsynaptic currents, 25 µM MK-801, 5 µM L-689-560 and 20 µM NBQX were included 
in the aCSF to antagonize NMDA and AMPA receptors. Whole cell voltage clamp recordings (−70 mV) from 
CA1 neurons were obtained with glass microelectrodes (4.5–6 MOhm) using a Multiclamp 700A amplifier (Axon 
Instruments, USA). To record miniature IPSCs, 1 µM TTX was added to aCSF. The data analysis was made with 
Mini Analysis Program, version 5.6.6 (Synaptosoft, USA).
Behavioural tests. Learned Helplessness test. The test was performed as described55. The protocol includes 
a pre-test session (PT) with 40 unescapable footshocks (0.4 mA, per 10 s) and on the 7th day a test session (T) in 
which 30 escapable footshocks (0.4 mA, per 10 s) are preceded (5 s) by an alarm tone (60 dB, 670 Hz). In the test 
session the shock could be interrupted or avoided by the animal if it crosses to the other compartment of the 
chamber during the tone presentation or during the footshock application. Twenty-four hours after the PT the 
animals were anesthetized with isoflurane.
Neuropathic pain model of depression. Neuropathic pain was induced by placing a cuff around the main branch 
of the right sciatic nerve under anesthesia22, 56. Sham-operated mice underwent the same procedure without cuff. 
The mechanical threshold of hindpaw withdrawal was evaluated using von Frey filaments56, 57. To assess anxio-
depressive phenotype the novelty suppressed feeding (NSF) test was done at 12th hour after the isoflurane/sham 
treatment22, 23.
Forced swim test. A mouse was placed into a glass cylinder (diameter 19 cm, height 24 cm) filled with water 
(21 ± 1 °C) to the height of 14 cm. Overall immobility was measured during the 6-minute testing period.
Open field test. General locomotor activity was investigated for 30 min in an illuminated (300 lux) transparent 
cage (length 28.5 × height 8.5 × width 20 cm). Interruptions of infrared photo beams were used to calculate the 
overall distance traveled (cm).
Statistical analysis. Results are represented as mean ± SEM (standard error of mean) unless otherwise 
stated. For statistical analysis two-sided tests including unpaired two-tailed Student’s t-test, Mann Whitney U 
test (non-normally distributed data), one-way analysis of variance (ANOVA), mixed model ANOVA, two-way 
ANOVA, Pearson’s χ2 test and Spearman’s correlation test were used. Levene’s test was used to define the equality 
of variances. If the variances differed significantly non-parametric test was used. Post hoc analysis was conducted 
with Tukey HSD or Dunnett’s test. Statistically significant p value was set to ≤ 0.05. Outliers were considered as 
values differing more than 2x standard deviation from the mean of the group. To calculate the proper sample 
sizes we used power calculations (α = 0.05 and power 0.80) and estimated the standard deviations and effect sizes 
based on our previous experience and literature.
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